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Psychostimulants induce neuroadaptations in excit-
atory and fast inhibitory transmission in the ventral
tegmental area (VTA). Mechanisms underlying drug-
evoked synaptic plasticity of slow inhibitory trans-
mission mediated by GABAB receptors and G
protein-gated inwardly rectifying potassium (GIRK/
Kir3) channels, however, are poorly understood.
Here, we show that 1 day after methamphetamine
(METH) or cocaine exposure both synaptically
evoked and baclofen-activated GABABR-GIRK
currents were significantly depressed in VTA GABA
neurons and remained depressed for 7 days. Presyn-
aptic inhibition mediated by GABABRs on GABA
terminals was also weakened. Quantitative immu-
noelectron microscopy revealed internalization of
GABAB1 and GIRK2, which occurred coincident
with dephosphorylation of serine 783 (S783) in
GABAB2, a site implicated in regulating GABABR sur-
face expression. Inhibition of protein phosphatases
recovered GABABR-GIRK currents in VTA GABA
neurons of METH-injected mice. This psychostimu-
lant-evoked impairment in GABABR signaling re-
moves an intrinsic brake on GABA neuron spiking,
which may augment GABA transmission in the mes-
ocorticolimbic system.
INTRODUCTION
Changes in the motivation for drugs and natural rewards are
central to the development of addiction (Koob and Volkow,978 Neuron 73, 978–989, March 8, 2012 ª2012 Elsevier Inc.2010). The mesocorticolimbic dopamine (DA) system is the
major brain reward circuit involved in translating motivations
into goal-directed behaviors. Within this system, natural rewards
increase activity of the ventral tegmental area (VTA) DA neurons,
which primarily project to the nucleus accumbens (NAc), amyg-
dala, and medial prefrontal cortex (mPFC). Addictive drugs
converge on the mesocorticolimbic DA system, however,
producing long-lasting changes in DA levels and excitability of
DA neurons (Koob and Volkow, 2010; Lu¨scher and Malenka,
2011). One of the key pathways for controlling DA neuron excit-
ability is through activation of a slow GABA-dependent inhibitory
current, mediated by GABAB receptors (GABABRs) and G
protein-gated inwardly rectifying potassium (GIRK/Kir3) chan-
nels (Johnson and North, 1992; Cruz et al., 2004; Laboue`be
et al., 2007) and through an auto-inhibitory pathway mediated
by D2 dopamine receptors (D2Rs) and GIRK channels (Johnson
and North, 1992; Beckstead et al., 2004). In vivo exposure to
psychostimulants leads to reduced sensitivity of D2 autorecep-
tors and increased DA neuron excitability (White and Wang,
1984; Henry et al., 1989;White, 1996), implicating GIRK channels
in the response to addictive drugs (Lu¨scher and Slesinger, 2010).
Consistent with this, mice lacking GIRK channels self-administer
less cocaine (Morgan et al., 2003) and show reduced withdrawal
after chronic exposure to morphine (Cruz et al., 2008). Further-
more, Girk2 transcripts in the mesocorticolimbic dopamine
pathway are increased in some human cocaine addicts (Lehr-
mann et al., 2003). Although GIRK channels are implicated in
the response to addictive drugs, the cellular mechanisms under-
lying drug-evoked changes in GIRK signaling are not well
understood.
Accumulating evidence suggests that acquisition of addictive
behaviors is learned and, similar to other learning and memory
models, involves persistent changes in synaptic strength
within the reward circuit and changes in DA neuron signaling
(Koob and Volkow, 2010; Lu¨scher and Malenka, 2011). Early
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Figure 1. Absence of Slow Inhibitory Postsynaptic
Currents in VTA GABA Neurons 24 Hr and 7 Days
following In Vivo METH Exposure
The slow inhibitory postsynaptic current (sIPSC) re-
corded from DA (A) and GABA (D) neurons in the VTA
24 hr following a saline (0.9%) or METH (2 mg/kg) in-
jection. The GABAB receptor antagonist CGP 54626
(2 mM) inhibited the sIPSC (light gray or light red trace).
The GABABR-sIPSC is reduced in the VTA GABA
neuron 24 hr following METH injection. Scale bars: 5 pA,
200 ms.
(B and E) Bar graphs show mean amplitudes for sIPSC
following saline or METH (24 hr and 7 days later) in DA
(B) (DA saline: 15.8 ± 1.5 pA; DA METH: 16.5 ± 2.8 pA;
DA 7 days METH: 16.1 ± 2.0 pA) and GABA (E) neurons
(GABA saline: 17.8 ± 2.6 pA; GABA METH: 0.7 ± 0.5 pA;
GABA 7 days METH: 1.5 ± 1.0 pA). The sIPSC is signifi-
cantly depressed 24 hr and 7 days following a single
injection of METH in GABA neurons (**p < 0.05 [one-way
ANOVA]).
(C and F) Box plots show GABAA receptor-mediated
IPSC paired-pulse ratio (PPR) plotted for DA (C) and
GABA (F) neurons in saline and METH -injected mice
(DA saline: 0.73 ± 0.10 pA; DA METH: 0.89 ± 0.09 pA; GABA saline: 1.20 ± 0.17 pA; GABA METH: 1.02 ± 0.11 pA (ns, p > 0.05 [Mann-Whitney test]). Line shows
mean. Insets show representative traces for each condition.
Scale bars: 100 pA, 20 ms. N (number of recordings) indicated on all graphs. All bar graphs show mean ± SEM.
Neuron
Depression of GABABR-GIRKs with Psychostimulantsdrug-evoked neuroadaptations are thought to occur within the
VTA and are critical for remodeling the reward circuit and facili-
tating the development of addiction. Lesion of VTA DA neurons
blocks drug-dependent addictive behaviors (Roberts and
Koob, 1982). Neuro-adaptations that occur 24 hr following expo-
sure to addictive drugs in vivo have been described. Systemic
injection of a psychostimulant strengthens excitatory synapses
in the VTA (White et al., 1995; Zhang et al., 1997; Ungless
et al., 2001; Borgland et al., 2004; Argilli et al., 2008) through
recruitment of GluA2-lacking AMPA receptors to the synapses
(Bellone and Lu¨scher, 2006; Argilli et al., 2008). Neuro-adapta-
tions in fast GABA transmission have also been reported; fast
inhibitory currents mediated by GABAA receptors are impaired
24 hr after a single injection of morphine (Nugent et al., 2007),
and the amplitudes of GABA-mediated synaptic currents are
reduced in mice receiving several injections of cocaine (Liu
et al., 2005). Chronic amphetamine enhances GABAB receptor
transmission in the VTA during early withdrawal, but the cellular
mechanism underlying this change is unknown (Giorgetti et al.,
2002). Following chronic cocaine or morphine treatment, D1R
stimulation decreases GABAB-GIRK currents in DA neurons,
but this occurs from a change in presynaptic GABA release
(Bonci and Williams, 1996). In this study, we sought to char-
acterize the early modulation of GABAB signaling by a single
exposure to psychostimulants. We discovered that 24 hr
following intraperitoneal (i.p.) injection of methamphetamine
(METH) or cocaine, GABAB receptor signaling in VTA GABA
neurons is strongly and persistently impaired. This drug-evoked
depression of GABABR-GIRK signaling involves dephosphoryla-
tion of the GABAB receptor and changes in GABABR and GIRK
channel trafficking. As a consequence, VTA GABA neuron firing
is not affected by the GABABR agonist baclofen, suggesting
GABAergic function may be augmented in the VTA with
psychostimulants.RESULTS
Psychostimulant-Evoked Plasticity in GABABR Signaling
in VTA
A single injection of psychostimulants enhances glutamatergic
synaptic efficacy in the VTA 24 hr later (Ungless et al., 2001;
Borgland et al., 2004; Argilli et al., 2008). We examined whether
a single injection of psychostimulant also alters GABABR-GIRK
signaling in the VTA. To test this, we injected C57BL/6 mice
with methamphetamine (METH) at 2 mg/kg, a dose that elicits
locomotor sensitization when administered repeatedly (Shimo-
sato et al., 2001; Fukushima et al., 2007; Scibelli et al., 2011)
and examined GABABR-GIRK signaling in the VTA 24 hr later.
We first investigated the synaptically activated GABABR-GIRKs,
commonly referred to as the slow inhibitory postsynaptic current
(sIPSC), in acutely prepared VTA slices. High frequency (66 Hz)
stimulation of GABA afferents induces a spillover of GABA that
diffuses to perisynaptic GABAB receptors and elicits a slow
outward K+ current (sIPSC; Figure 1). The GABAB receptor
antagonist, CGP 54626 (2 mM), inhibited the evoked current,
confirming the identity of the GABAB sIPSC (Figure 1), similar
to previous studies (Johnson and North, 1992; Bonci and
Williams, 1996). In DA neurons, the GABAB sIPSC did not signif-
icantly change 24 hr following METH, compared to saline injec-
tion (Figures 1A and 1B). By contrast, the sIPSCwas significantly
smaller in GABA neurons (Figures 1D and 1E). Moreover, the
sIPSC in GABA neurons remained depressed for at least
7 days (Figure 1E). Examination of the paired-pulse ratio for the
fast GABAA-mediated IPSC revealed no difference in either DA
or GABA neurons (Figures 1C and 1F), suggesting that the
depression of the sIPSC in GABA neurons was not due to the
inability of GABA terminals to release GABA.
To investigate the effects of METH on synaptic and extrasy-
naptic GABAB receptors, the GABAB receptor agonist baclofenNeuron 73, 978–989, March 8, 2012 ª2012 Elsevier Inc. 979
saline
**
**
0
20
40
60
12 11 18
7d24h24h
BA
C D saline METH
7d24h24h
Baclofen
Ba2+ Baclofen
Ba2+
Baclofen Ba2+ Baclofen Ba2+
DA
METH
DA
saline
GABA
METH
GABA
saline METH
0
100
200
300
12 17 15
**
I B
ac
lo
fe
n
(pA
)
I B
ac
lo
fe
n
(pA
)
Figure 2. Reduced GABABR-GIRK Currents in VTA GABA Neurons
24 Hr and 7 Days following In Vivo METH Exposure
The baclofen-activated GIRK currents (IBaclofen) recorded from VTA DA (A) and
GABA (C) neurons 24 hr following a saline (0.9%) or METH (2 mg/kg) injection.
Outward currents recorded at50mV are plotted as a function of time. IBaclofen
is blocked by the inward rectifier inhibitor Ba2+ (1 mM) or by the GABABR
antagonist CGP 54626 (data not shown).
Scale bars: 100pA (A) 50 pA (C), 100 s.
(B) Bar graph shows average IBaclofen in DA neurons 24 hr following saline (DA
saline: 278 ± 37 pA) or 24 hr and 7 days following METH injection (DA METH:
174 ± 19; DA 7 days METH: 229 ± 21 pA).
(D) Bar graph shows average IBaclofen in GABA neurons 24 hr following saline
injection (GABA saline: 48.4 ± 5.3 pA) or 24 hr and 7 days following METH
injection (GABA METH: 22.9 ± 4.7; GABA 7 days METH: 19.4 ± 4.5 pA). Note
significant decrease in IBaclofen in GABA neurons of METH-injected mice that
persists for 7 days (**p < 0.05 [one-way ANOVA]).
Neuron
Depression of GABABR-GIRKs with Psychostimulantswas applied to the bath. As described previously (Laboue`be
et al., 2007), saturating doses of baclofen (300 mM for DA and
100 mM for GABA) elicited large and desensitizing GABABR-acti-
vated GIRK currents in DA neurons and small nondesensitizing
currents in GABA neurons (Figure 2). All baclofen-activated
currents were inhibited with the inwardly rectifying K+ channel
inhibitor Ba2+ or the GABAB receptor antagonist (CGP 54626,
not shown). In contrast to the sIPSC recordings, there was an
40% decrease in the GABABR-GIRK currents of DA neurons
24 hr following a METH injection (Figures 2A and 2B). However,
this decrease in current was not apparent at 7 days following
METH injection (Figure 2B). By contrast, the baclofen-activated
GIRK (IBaclofen) currents in GABA neurons were significantly
depressed by 55% 24 hr following a single METH injection
and the reduced IBaclofen persisted for 7 days (Figures 2C and
2D). We next examined whether METH altered GABABR-GIRK
signaling in other brain regions. There was no significant change
in the sIPSC or IBaclofen in CA1 hippocampal pyramidal or
GABAergic neurons 24 hr following METH (Figure S1 available
online). We also measured the sIPSC and IBaclofen in pyramidal
and GABAergic neurons of the prelimbic cortex, a target region
of VTA DA cells, and observed no significant changes in
GABAB-GIRK currents in METH-injected mice (Figure S1).
Thus, a single exposure to METH triggered a profound and
long-lasting depression in both the sIPSC and IBaclofen in GABA
neurons of the VTA.
In addition to postsynaptic GABAB receptors, presynaptic
GABAB receptors are also involved in reducing GABA release,
typically through inhibition of voltage-gated Ca2+ channels
(Padgett and Slesinger, 2010). To investigate whether in vivo
exposure to METH altered GABAB receptor-dependent presyn-
aptic inhibition, we used an optogenetic strategy to selectively
stimulate GABA neurons in the VTA and measure the effect of
baclofen on a light-evoked fast inhibitory postsynaptic current
(IPSC) recorded in DA neurons (Figure 3). AAV virus expressing
a double floxed-stopped channel rhodopsin 2 (ChR2)-eYFP
was stereotaxically injected into the VTA of mice expressing
Cre recombinase in GABA neurons (GAD65-Cre; Figure 3A; Fig-
ure S2). After 21 days, neurons expressing ChR2-eYFP were
evident in horizontal slices of the VTA (Figure S2A). Prolonged
blue light stimulation (400ms) elicited tetrodotoxin (TTX)-insensi-
tive photocurrents in GABA neurons, whereas short light pulses
(4 ms) evoked picrotoxin- and TTX-sensitive fast IPSCs in DA
neurons (Figures S2B and 2SC; Figure 3B). Bath application of
baclofen (1 mM) depressed the light-evoked IPSC by 50% in
saline-injected mice. By contrast, baclofen (1 mM) decreased
the light-evoked IPSC by only 20% in METH-injected mice
(Figures 3B and 3C). Construction of dose-response curves
revealed that GABAB receptor-dependent inhibition of presyn-
aptic release was shifted significantly to higher agonist concen-
trations (Figure 3C), reflected by an increase in the IC50, which is
the concentration of Baclofen needed to inhibit 50% of the
light-induced current (Figure 3D). Similar to the change in post-
synaptic GABABR-GIRK signaling, the reduced sensitivity of
presynaptic GABABRs persisted for 7 days (Figures 3C and
3D). As a control, we examinedGABABR-dependent presynaptic
inhibition of glutamate release onto DA neurons by measuring
the amplitude of electrically evoked AMPA EPSC, in the pres-980 Neuron 73, 978–989, March 8, 2012 ª2012 Elsevier Inc.ence of increasing concentrations of baclofen (Figure S3). We
found no significant change in the IC50 in METH-injected mice,
compared to saline controls. Taken together, these results
demonstrate that a single in vivo injection of METH triggers
a depression in GABAB receptor signaling in VTAGABA neurons,
both presynaptically (inhibition of GABA release) and postsynap-
tically (activation of GIRK channels).
Psychostimulant-Evoked Plasticity in GABABR
Involves Dopamine
Cocaine is another psychostimulant that rapidly elevates DA
levels within minutes after the injection. In contrast to METH,
which is taken up by DA neurons and stimulates reverse trans-
port of DA through the dopamine transporter (DAT), cocaine
inhibits DAT from the extracellular side (Sulzer, 2011). We
examined whether a single injection of cocaine would evoke
a change in GABABR-GIRK signaling. Like METH, cocaine
(15 mg/kg) produced a significant decrease in the sIPSC in
GABA neurons but not in DA neurons 24 hr later (Figures 4A–
4D). Similarly, IBaclofen was depressed in GABA neurons but
not in DA neurons (Figures 4E–4H). Thus, both cocaine and
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Figure 3. Reduced Sensitivity of Presyn-
aptic GABAB Receptor-Mediated Inhibition
24 hr and 7 days following In Vivo METH
Exposure
(A) Schematic shows channel rhodopsin 2 (ChR2)
protein expressed selectively in VTA GABA
neurons of GAD65-Cre mice. GABA neuron
activity is induced by blue light, resulting in a fast
GABAA receptor-mediated IPSCs recorded from
VTADA neuron. Baclofen impairs GABA release by
acting on presynaptic GABAB receptors.
(B) Example traces of blue light-evoked IPSCs
recorded 24 hr following saline or METH injection
in presence of increasing concentrations of ba-
clofen (mM). Blue ticks indicate light stimulation
(two 4 ms pulses). Basal IPSC amplitude recovers
after application of CGP 54626 (2 mM) and is
subsequently blocked by picrotoxin (100 mM).
Scale bars: 200 pA, 10 ms.
(C) Dose response curves show reduced sensi-
tivity for baclofen-dependent inhibition of fast
IPSCs in METH injected mice after 24 hr and
7 days.
(D) Bar graph plots IC50 for indicated conditions
(saline: 1.2 ± 0.4 mM; 24 hr METH: 7.1 ± 2.4 mM;
7 day METH: 9.4 ± 1.4 mM (**p < 0.05 [one-way
ANOVA]).
Neuron
Depression of GABABR-GIRKs with PsychostimulantsMETH trigger a similar neuroadaptation in GABABR-GIRK
signaling in GABA neurons of the VTA, suggesting that elevated
DA may be an important step in inducing the GABABR-GIRK
plasticity.
Dopamine stimulates two classes of DA receptors, D1- and
D2-like receptors, in the brain (White, 1996). D1-like receptor
antagonists block sensitization to psychostimulants (Kalivas
and Stewart, 1991), reduce self-administration of cocaine (Caine
et al., 2007), and prevent psychostimulant-induced changes in
glutamatergic signaling in the VTA (Argilli et al., 2008; Brown
et al., 2010). To test the requirement for DA receptors, we in-
jected an antagonist for D1-like (SCH39166) or D2-like (Eticlopr-
ide) receptors with METH (Figure 5). In contrast to injection of
METH alone, the sIPSC recorded from mice injected with
METH and SCH39166 (0.3 mg/kg) was not significantly different
from saline (Figures 5A and 5B). By contrast, co-injection of
Eticlopride (0.1 mg/kg) with METH did not attenuate the
METH-dependent decrease in sIPSC. For macroscopic
GABABR-GIRK currents, co-injection of METH and SCH39166
also partially blocked the METH-dependent decrease in IBaclofen
(Figures 5C and 5D). Interestingly, co-injection of Eticlopride with
METH attenuated the METH-dependent decrease in IBaclofen
(Figures 5C and 5D), in contrast to the effect of Eticlopride on
the sIPSC. This could reflect a difference in synaptically and
extrasynaptically activated GABAB receptors. For cocaine,
co-injection of METH or cocaine with both SCH39166 and
Eticlopride partially recovered the sIPSC, compared to saline-
injected controls (Figures 5B and 5D). Together, these pharma-
cological experiments clearly implicate DA and the D1-like
receptor in mediating psychostimulant-dependent depression
in GABABR-GIRK signaling in VTA GABA neurons, similar to
the plasticity changes in excitatory synapses in VTA DA neurons
following cocaine (Argilli et al., 2008).Cellular Mechanism Underlying Depression
of GABABR-GIRK Signaling
A reduction in the amplitude of GABAB-GIRK currents could
involve a change in G protein coupling (Nestler et al., 1990;
Laboue`be et al., 2007), desensitization of GABAB receptors
(Taniyama et al., 1991; Gonza´lez-Maeso et al., 2003), and/or
internalization of the receptor channel (Fairfax et al., 2004; Guetg
et al., 2010; Maier et al., 2010; Terunuma et al., 2010). To inves-
tigate the latter possibility, we used quantitative immuno-elec-
tron microscopy to study the subcellular distribution of GABAB
receptors and GIRK channels in saline- and METH-injected
mice. In serial ultrathin sections through the VTA, GABA neurons
were identified using antibodies against GAD65/67 and sec-
ondary antibodies coupled to horseradish peroxidase (HRP),
generating a dark reaction product in GABA neurons (Figures
6A and 6B). VTA sections were also labeled with immunogold
particles using specific antibodies for GABAB1 or GIRK2 (Kulik
et al., 2003; Koyrakh et al., 2005). In single ultrathin sections
(Figures 6A and 6B), both GABAB1 and GIRK2 were expressed
predominantly at the plasma membrane of GABA neuron
dendrites (Den; arrows) following saline injection. By contrast,
24 hr following aMETH injection, there was a reduction in plasma
membrane associated GABAB1 and an increase at intracellular
sites (Figure 6A, crossed arrows). Similarly, therewas a reduction
in GIRK2 protein on the plasma membrane and an increase in
intracellular compartments in GABA neurons following METH
treatment (Figure 6B). To quantify these changes, we generated
a three-dimensional reconstructionof thedendrite using the serial
ultrathin sections (Figures 6C and 6D) and then counted gold
particles on the plasma membrane and in the cytoplasm. Calcu-
lating the surface and intracellular densities (Figures 6E and 6F)
revealed that 24 hr following METH injection there was a signifi-
cant reduction (60%–70%) in plasma membrane-associatedNeuron 73, 978–989, March 8, 2012 ª2012 Elsevier Inc. 981
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Figure 4. Depression of GABABR-GIRK
Signaling in VTA GABA Neurons 24 hr
following a Single Cocaine Injection
(A–D) The sIPSC is reduced in VTA GABA (C) but
not in DA (A) neurons 24 hr following a single
cocaine (15 mg/kg) injection. Scale bars: 5 pA,
200 ms. Only recordings from cocaine-injected
mice are shown. Light blue trace shows sIPSC
recorded with CGP 54626 (2 mM).
(B and D) Bar graphs show mean amplitudes for
sIPSC 24 hr following saline or cocaine (DA saline:
17.6 ± 2.6 pA; DA cocaine: 15.3 ± 3.1 pA; GABA
saline: 15.7 ± 2.8 pA; GABA cocaine: 2.9 ± 1.6 pA).
(E–H) The baclofen-induced GIRK current (IBaclofen)
is reduced in VTA GABA (G) but not DA (E) neurons
24 hr following cocaine (15 mg/kg) injection.
Traces show current recorded at 50 mV with
baclofen (100 mM) or Ba2+ (1 mM). Scale bars:
50 pA, 100 s.
(F) Bar graph shows average IBaclofen in DA neurons 24 hr following saline or cocaine injection. (DA saline: 269 ± 27; DA cocaine: 225 ± 16 pA).
(H) Bar graph shows average IBaclofen in GABA neurons 24 hr following saline or cocaine injection (GABA saline: 47.7 ± 8.9; GABA cocaine: 20.4 ± 3.8 pA).
**p < 0.05 (Student’s t test).
Neuron
Depression of GABABR-GIRKs with PsychostimulantsGABAB1 and GIRK2, with a concomitant increase in the intracel-
lular-associated GABAB1 and GIRK2 (50%–65%). By contrast,
we did not observe a significant change in immunogold particle
labeling of plasma membrane staining for GIRK2 and GABAB1
in GAD65/67-negative neurons (GIRK2: 0.924 ± 0.032 particles/
mm2 saline versus 0.843 ± 0.054 METH, n = 21 and GABAB1:
1.042 ± 0.043 saline versus 0.922 ± 0.050 GABAB1; p > 0.05).
Interestingly, the reduction in plasma membrane-associated
GIRK2 and GABAB1 parallels the 50% depression in baclofen-
induced GABABR-GIRK currents (Figure 2F). Moreover, the rela-
tive decreases in GABAB1 and GIRK2 protein on the plasma
membrane are very similar, suggesting the GABAB receptor and
GIRK channel may internalize as a signaling complex from the
plasma membrane (Boyer et al., 2009). Taken together, these
data demonstrate that 24 hr after a single injection of METH,
both GABAB receptor and GIRK channel protein levels are
reduced on the plasma membrane of GABA neurons, providing
a reasonable explanation for depressed GABABR-GIRK currents
in those neurons.
The quantitative immunogold electron microscopy data sug-
gested that METH treatment induced internalization of the
receptor and channel. The phosphorylation status of the
GABAB receptor is important for regulating surface expression
of the receptor (Fairfax et al., 2004; Koya et al., 2009; Guetg
et al., 2010; Terunuma et al., 2010). We therefore examined
whether phosphorylation of the GABAB receptor could play
a role in mediating the METH-dependent depression. We exam-
ined the phosphorylation of S783 (p-S783) in GABAB2 because
dephosphorylation is associated with reduced surface expres-
sion of GABAB receptors in neurons (Terunuma et al., 2010).
Protein isolated from tissue punches of the VTA, NAc, hippo-
campus, or mPFC from saline- and METH-injected mice (24 hr)
were examined using a phospho-specific antibody for phos-
phorylated S783 in GABAB2 (Dobi et al., 2010). Remarkably,
METH injection led to a 25% reduction in phosphorylation of
GABAB2-S783 in the VTA (Figure 7A). This change in p-S783
compares to a METH-induced 50% reduction in IBaclofen in982 Neuron 73, 978–989, March 8, 2012 ª2012 Elsevier Inc.GABA neurons (Figure 2D). However, the VTA tissue punches
contain a mixture of cell types that express GABAB receptors,
which likely account for the smaller change in GABAB2-p-S783.
By contrast, there was no change in GABAB2-p-S783 in the
NAc,mPFC, or hippocampus fromMETH -injectedmice (Figures
7B–7D). Examination of p-S892, a different phosphorylation site
onGABAB2 (Fairfax et al., 2004), revealed no change in phospho-
specific labeling of GABAB2-p-S892 in METH-injected mice,
indicating the effect of METH was unique to GABAB2-S783
(Figure 7E). Lastly, there was no apparent change in the
levels of GABAB2 receptor protein (Figure 7F), suggesting little
METH-dependent degradation of receptor.
Dephosphorylation of GABAB2-p-S783 has been previously
shown to be regulated by protein phosphatase 2A (PP2A;
Terunuma et al., 2010), raising the possibility that in vivo expo-
sure to METH enhances the phosphatase activity in VTA GABA
neurons. To address this, we examined the effect of acutely
inhibiting PP1/PP2A phosphatases with okadaic acid (OA;
100 nM). In saline-injected mice, there was no significant differ-
ence in the amplitude of IBaclofen with OA in the pipet, suggesting
that basal activity of PP1/PP2A does not significantly regulate
GABABR-GIRKs (Figures 7G–7J). In METH-injected mice,
however, intracellular application of OA promoted recovery of
the IBaclofen (Figures 7H and 7J). Note the slow time course of
activation for IBaclofen in the presence of OA in METH-injected
mice. This increase could reflect insertion of GABAB receptors
and GIRK channels on the plasma membrane or restoration of
functional G protein coupling. For control, we examined the
effect of PKC(19-36), a peptide inhibitor of PKC (Figure 7K).
Unlike OA, the presence of PKC inhibitor in the pipet did
not restore IBaclofen, similar to the effect of METH alone.
Taken together, these findings suggest that in vivo exposure to
METH triggers a phosphatase-dependent downregulation of
GABABRs and GIRK channels from the plasma membrane of
GABA neurons, which results in reduced GABABR-GIRK
signaling and accumulation of GABAB receptor complexes in
intracellular compartments.
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Figure 5. D1-like Receptor Antagonist
Blocks METH-Induced Depression in
GABABR-GIRK Signaling
(A) The sIPSC recorded from VTA GABA neurons
in a VTA slice from mice co-injected with saline
and D1-like receptor antagonist (SCH39166;
0.3 mg/kg)/D2-like receptor antagonist (Eti-
clopride; 0.1 mg/kg), METH and SCH39166, or
METH and Eticlopride. The GABAB receptor
antagonist CGP 54626 (2 mM) inhibited the sIPSC.
Scale bar: 5 pA, 200 ms.
(B) Bar graph shows the average sIPSC in VTA
GABA neurons (saline + SCH39166/Eticlopride:
11.9 ± 1.6pA; METH + SCH39166: 9.2 ± 1.7 pA;
METH + Eticlopride: 2.5 ± 1.4 pA; cocaine +
SCH39166/Eticlopride 6.8 ± 1.2 pA (**p < 0.05
versus saline [one-way ANOVA]).
(C) IBaclofen recorded from mice co-injected with
saline and SCH39166/Eticlopride, METH and
SCH39166, or METH and Eticlopride. Scale bar:
50 pA, 100 s.
(D) Bar graph shows the average IBaclofen (saline + SCH39166/Eticlopride: 44.4 ± 12.5 pA; METH + SCH39166: 27.3 ± 4.1 pA; METH + Eticlopride: 23.0 ± 9.7 pA;
METH + SCH39166/Eticlopride: 27.3 ± 7.8 pA; cocaine + SCH39166/Eticlopride 55.7 ± 17.8 pA (p > 0.05, not significant from saline).
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Depression of GABABR-GIRKs with PsychostimulantsLoss of GABABR-Dependent Inhibition of VTA GABA
Neuron Firing
To investigate the functional consequence of reduced GABABR-
GIRK currents in GABA neurons of METH-injected mice, we
examined the effect of baclofen on the induced firing rate of
GABA neurons (Figure 8). We predicted that a loss of
GABABR-GIRK signaling would attenuate GABABR-mediated
suppression of firing in GABA neurons. To test this, a series of
current steps (20–100 pA) were injected to elicit a train of action
potentials in GABA neurons (Figures 8A and 8B). In saline- and
METH-injected mice, the input-output (I-O) plot shows a linear
increase in firing rate with larger current injections (Figures 8B
and 8D). As expected, baclofen (100 mM) significantly sup-
pressed firing in GABA neurons of saline-injected mice,
decreasing the slope of the I-O curve (Figures 8A and 8B). By
contrast, a saturating dose of baclofen (100 mM) did not signifi-
cantly change the I-O curve in METH-injected mice (Figures 8B
and 8C). These results demonstrate that a loss of GABABR-
GIRK currents in GABA neurons removes an important ‘‘brake’’
on GABA neuron firing in the VTA.
DISCUSSION
Drug-evoked synaptic plasticity can cause persistent modifica-
tions of neural circuits that eventually lead to addiction. We
report here that a single dose of METH or cocaine is sufficient
to significantly weaken the ability of GABAB receptors to control
VTA GABA neuron firing when measured ex vivo 24 hr later. As
such, this adaptive change is not likely sufficient to cause addic-
tion but rather represents a building block of the adaptations that
underlie addictive behavior with repetitive exposure. Studying
the effect of a single injection of drug enabled us to systemati-
cally probe the mechanism underlying the plasticity of the slow
IPSC. We discovered the methamphetamine-induced loss of
the slow IPSC arises from a reduction in the GABABR-GIRK
currents, due to changes in protein trafficking, and is accompa-nied by a significant decrease in the sensitivity of presynaptic
GABAB receptors in GABA neurons of the VTA. In contrast,
GABA neurons of the hippocampus and prelimbic cortex
did not show similar changes in GABAB-GIRK signaling, sug-
gesting the GABABRs in the VTA are uniquely targeted by
psychostimulants.
The psychostimulant-evoked reduction of GABAB-GIRK
currents in VTA GABA neurons could arise from a change in G
protein coupling (Nestler et al., 1990; Laboue`be et al., 2007) or
internalization of the receptor-channel (Gonza´lez-Maeso et al.,
2003; Fairfax et al., 2004; Guetg et al., 2010; Maier et al., 2010;
Terunuma et al., 2010). In support of the latter possibility, quan-
titative immunogold electron microscopy revealed a significant
reduction in surface expression of GABAB receptors and GIRK
channels in GABA neurons of METH-injected mice, coincident
with a decrease in phosphorylation of GABABRs. In cortical
and hippocampal neurons, a balance of AMP-activated protein
kinase (AMPK)-dependent phosphorylation of GABAB2-S783
and PP2A-dependent dephosphorylation governs postendo-
cytic sorting of GABAB receptors (Terunuma et al., 2010). The
persistence of the GABAB-GIRK depression and the rapid
recovery with phosphatase inhibitors suggest the balance of
surface and internalized GABAB receptors in GABA neurons
might be controlled by a molecular switch in a phosphatase,
perhaps akin to the autophosphorylation switch in CaMKII (Luc-
chesi et al., 2011) or through an endogenous regulator of protein
phosphatase activity (Guo et al., 1993). It remains possible that
other kinases are also involved; both PKA- and CaMKII-depen-
dent phosphorylation have been implicated in stabilization of
GABAB1 on the plasma membrane (Couve et al., 2002; Guetg
et al., 2010). Interestingly, total protein levels of GABAB2
receptors were not significantly changed in METH-injected
mice, suggesting that the internalized pool of receptors was
not redirected to a degradation pathway, in contrast to
activity-dependent degradation of GABAB receptors observed
in cortex (Terunuma et al., 2010). If phosphorylation controlsNeuron 73, 978–989, March 8, 2012 ª2012 Elsevier Inc. 983
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Figure 6. Reduced Surface Expression of GABAB1
Receptors and GIRK2 Channels in GABA Neurons
of METH-Injected Mice
(A and B) Pre-embedding double-labeling electron
microscopy reveals GABAB1 and GIRK2 expression in
GABAergic neurons of the VTA 24 hr following saline or
METH injection. GABA neurons were identified by GAD65/
67-HRP immunoreactivity (labeled Den). Immunogold
particles identify GABAB1 or GIRK2. A reduction in im-
munogold particles against GIRK2 or GABAB1 along the
plasma membrane (arrows) was clearly detected in
GAD65/67 positive dendrites following METH injection; an
increase in immunogold particles against GIRK2 and
GABAB1 at intracellular sites can also be seen (crossed
arrows). Right panels in (A) and (B) show zoom of boxed
area.
Den, dendrite; ax, axon; mit, mitochondria. Scale bars:
0.5 mm.
(C) and (D) Three-dimensional reconstructions of dendrites
from serial electronmicrographs. Note decrease in surface
expression of GABAB1 receptors (C) and GIRK2 (D)
following METH treatment. Black dots represent im-
munogold particles on the front surface and gray dots
show immunogold particles on the back side of the
dendrite. Blue regions are excitatory synapses. Note
immunogold particles are abundantly distributed over the
dendritic plasma membrane in control mice. Scale bars:
0.5 mm.
(E and F) Bar graphs show quantification of immunogold
particles in reconstructed GAD65/67-positive dendrites
for plasma membrane associated (GABAB1 saline: 16.0 ±
2.7; GABAB1 METH: 4.8 ± 0.8; GIRK2 saline: 14.1 ± 2.6;
GIRK2 METH: 5.3 ± 1.0 particles/mm3) and intracellular
particles (GABAB1 saline: 15 ± 3.6; GABAB1 METH: 29.9 ±
6.2; GIRK2 saline: 20.7 ± 2.6; GIRK2 METH: 62.3 ± 10.5
particles/mm3). Immunogold particles against both
GABAB1 and GIRK2 are significantly reduced at the
dendritic plasma membrane and increased at intracellular
sites 24 hr after METH injection (**p < 0.05 [Student t test]).
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Depression of GABABR-GIRKs with Psychostimulantssurface expression of GABAB receptors, then what controls
the surface expression of GIRK channels? CaMKII-dependent
phosphorylation of GIRK2 has been implicated in stabilizing
GIRK2 channels on the plasma membrane of hippocampal
neurons (Chung et al., 2009). In these neurons, protein
phosphatase-1-mediated dephosphorylation promotes GIRK
channel recycling and increases surface expression (Chung
et al., 2009); therefore, a phosphatase inhibitor would be ex-
pected to reduce GIRK expression on the plasma membrane.
An alternative explanation is that GIRK channels internalize via
association with GABAB receptors in amacromolecular signaling
complex. Previous studies have shown that both GPCRs and
GIRK channels are physically close (Lavine et al., 2002; Nobles
et al., 2005; Riven et al., 2006; Fowler et al., 2007) and can traffic
together through intracellular compartments (Clancy et al.,
2007).
Psychostimulants, such as METH and cocaine, generally lead
to elevations in DA (Sulzer, 2011) that signals through two
classes of GPCRs, D1- and D2-like receptors. Activation of
D1-like receptors is required for inducing locomotor sensitization
(Kalivas and Stewart, 1991), establishing self-administration of984 Neuron 73, 978–989, March 8, 2012 ª2012 Elsevier Inc.cocaine (Caine et al., 2007), and potentiating excitatory
synapses with psychostimulants (Argilli et al., 2008; Brown
et al., 2010). Supporting a role for D1-like receptors, co-injection
of a D1-like receptor antagonist significantly attenuated the
psychostimulant-dependent depression of GABABR-GIRK cur-
rents in VTA GABA neurons. We also observed some effects of
the D2-like antagonist and cannot completely rule out a compo-
nent of D2-like receptor activation in the depression of GABAB-
GIRK signaling. Recently, an acute cocaine-induced weakening
of baclofen-induced GIRK currents in VTA DA neurons was
found to be sensitive to D2-like, but not D1-like, receptor antag-
onists (Arora et al., 2011). In addition to DA, other neurotrans-
mitters may be involved in the psychostimulant-dependent
depression of GABABR-GIRK signaling. For example, acetylcho-
line levels in the VTA also increase following a single METH injec-
tion (Dobbs and Mark, 2008), and neuropeptides, such as
hypocretin/orexin, BDNF, and CRF, could be also involved in
the response to addictive drugs (Wang et al., 2005; Borgland
et al., 2006; Hyman et al., 2006; Pu et al., 2006). Condi-
tional knockouts or selective pharmacological experiments will
be needed to pinpoint the neurotransmitters involved in the
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Figure 7. Role of Dephosphorylation of GABABRs in METH-Depen-
dent Depression of GABABR-GIRK Currents in GABA Neurons
(A–D) Western blots using phospho-specific antibody for p-S783 in GABAB2
and total GABAB2 in tissue punches of VTA, NAc, PFC, and hippocampus from
saline and METH-injected mice (6–7 mice per group). Bar graphs show
quantification of western blots normalized to GABAB2 levels. Note significant
decrease in p-S783 in VTA (**, p < 0.05 [Student’s t test]).
(E) Western blot and quantification for p-S892 in GABAB2 and total GABAB2
in VTA.
(F) Western blot and quantification for total GABAB2 and GAPDH in VTA.
(G–I) Intracellular application of OA but not PKC inhibitor recovered IBaclofen in
METH-injected mice. Representative recordings of IBaclofen in GABA neurons
from saline andMETH-injectedmice are shown with 100 nM okadaic acid (OA)
included in patch electrode (OApipet) (Vm = 50 mV). Scale bars: 10 pA, 100 s.
(J) Bar graph shows average IBaclofen for saline-injected/OApipet (38.3 ± 6.3 pA),
METH-injected/OApipet (40.2 ± 9.4 pA), and METH-injected (14.1 ± 5.6 pA).
(**p < 0.05 versus saline using [one-way ANOVA]).
(K) For control, a PKC inhibitor (PKC(19-36), 1 mM) included in the pipet
(PKCipipet) did not recover IBaclofen in METH-injected mice (saline+ PKCipipet:
31.5 ± 3.9 pA; METH+ PKCipipet: 17.5 ± 5.7pA; *p < 0.05 [Student’s t test]).
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Figure 8. METH-Injected Mice Lack GABABR-Dependent Inhibition
of VTA GABA Neuron Firing
(A and C) Current clamp recordings show spiking of VTA GABA neurons eli-
cited by a current injection (40 pA) in saline (A) and METH- (C) injected mice
24 hr later. Spiking recorded in the absence (top trace) and presence (bottom
trace) of 100 mM baclofen. Scale bars: 250 ms, 40 mV.
(B and D) Input-output graphs show spike number in GABA neurons plotted as
a function of current injection for saline (B, N = 7) and METH-injected mice
(D, N = 7). Average spike number increases with current injections and is
significantly suppressed by 100 mM baclofen in saline-injected mice (B).
*p < 0.05 two-way repeated-measure ANOVA. In METH-injected mice (D),
baclofen does not significantly suppress spiking (ns, p > 0.05).
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Depression of GABABR-GIRKs with Psychostimulantspsychostimulant-dependent depression of GABABR-GIRK re-
sponses in VTA GABA neurons.
How may the psychostimulant-evoked depression in GABAB-
GIRK signaling in VTA GABA neurons alter the physiology of the
VTA and contribute to addiction? DA neurons fire in two modes,
tonic and phasic, with phasic firing leading to higher DA levels
(Cooper, 2002). A balance of NMDAR activation and GABABR
signaling controls tonic versus phasic firing, and activation of
GABAB receptors plays an important role in reducing phasic
firing in VTA DA neurons (Erhardt et al., 2002). The VTA GABA
neurons provide a local source of GABA for controlling the firing
of VTA DA neurons (Grace and Bunney, 1985; Johnson and
North, 1992; Tan et al., 2010). Recent electron microscopy
studies have confirmed synaptic contacts between local GABA
and DA neurons within the VTA (Omelchenko and Sesack,
2009). In the present study, we demonstrate the functionality ofNeuron 73, 978–989, March 8, 2012 ª2012 Elsevier Inc. 985
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Depression of GABABR-GIRKs with PsychostimulantstheseGABAergic synapses using optogenetic tools. The depres-
sion of GABABR-GIRK signaling in somatodendritic regions
along with the reduced sensitivity of GABABRs in presynaptic
GABA terminals of VTA GABA neurons would markedly impair
an intrinsic ‘‘brake’’ on GABA release several days after a single
injection of METH. Together, these pre- and postsynaptic neuro-
adaptations are predicted to increase GABA-mediated inhibition
of VTA DA neurons. In line with this model, other groups have re-
ported psychostimulant-evoked neuro-adaptations in GABABR-
signaling that lead to enhanced GABAergic transmission in the
VTA (Giorgetti et al., 2002), the dorsolateral septal nucleus (Shoji
et al., 1997), and the NAc (Xi et al., 2003). Similarly, chronic
morphine increases the sensitivity of GABAB receptors on gluta-
matergic terminals in the VTA, which would further enhance the
inhibition of DA neurons mediated by augmented GABA release
(Manzoni and Williams, 1999).
An enhanced GABAergic inhibition of VTA DA neurons may
represent an attempt to restore balance in activity of the VTA
circuit; therefore, this GABABR-GIRK adaptation may be consid-
ered a form of synaptic scaling. Neuro-adaptive changes in
GABABR-GIRK signaling for re-establishing balance in neural
circuits have been described in other model systems. In amouse
model of succinic semialdehyde dehydrogenease deficiency, an
autosomal recessive disorder of GABA catabolism that leads to
elevated synaptic GABA, GABABR-GIRK currents are signifi-
cantly depressed in cortical neurons (Vardya et al., 2010). On
the other hand, the GABABR-mediated IPSC in hippocampal
pyramidal neurons is enhanced in response to potentiation of
excitatory synaptic transmission (Huang et al., 2005). The level
of inhibition mediated by GABABR-GIRK currents may be tightly
tuned to changes in neuronal excitability.
The downregulation of GABAB receptor signaling in VTA
GABA neurons occurs in parallel with other plastic changes in
VTA DA neurons, such as the redistribution of AMPAR and
NMDARs (White et al., 1995; Zhang et al., 1997; Ungless
et al., 2001; Borgland et al., 2004; Argilli et al., 2008; Mameli
et al., 2011), and alterations of fast GABAergic transmission
(Nugent et al., 2007). As proposed above, the drug-evoked
depression of GABABR signaling in GABA neurons removes
a ‘‘brake’’ on GABA neuron firing that may enhance GABA-
mediated inhibition of DA neurons. If present in vivo, the
increase in GABA transmission may reduce reward perception
(Koob and Volkow, 2010; Lu¨scher and Malenka, 2011).
However, repeated psychostimulant administration leads to
increases in the firing rates of VTA DA neurons (White and
Wang, 1984; Henry et al., 1989; White, 1996), partly through
reduced sensitivity of D2 autoreceptors (White, 1996). Thus,
an increase in GABA-mediated inhibition of VTA DA neurons,
whereas efficient at first, may eventually be inadequate to
suppress the potentiating effects of psychostimulants on VTA
DA neurons and is therefore unable to avert the progression
toward addiction. Enhancing this inhibitory pathway, however,
might provide a strategy for treating addiction. Clearly, addi-
tional experiments will be needed to better understand how
the adaptation of GABABR-GIRK signaling affects VTA GABA
neuron function and, more generally, the role of the slow
GABAB-mediated inhibition in drug-evoked remodeling of the
mesocorticolimbic circuitry.986 Neuron 73, 978–989, March 8, 2012 ª2012 Elsevier Inc.In conclusion, we have identified a molecular switch in GABAB
receptor signaling that occurs in response to a single in vivo
exposure to psychostimulant—this depression of GABABR-
GIRK signaling persists for days after the injection. This cellular
memory trace of drug exposure is encoded in a phosphoryla-
tion-dependent depression of GABAB receptor signaling in VTA
GABA neurons, which may augment GABA transmission in the
mesocorticolimbic system.
EXPERIMENTAL PROCEDURES
Animals
C57BL/6 mice were purchased from Harlan laboratories or bred in-house and
housed under constant temperature and humidity on a 12 hr light-dark cycle
(light 6 am–6 pm) with free access to food and water. GAD67-GFP is
a knock-in mouse that was kindly provided by Dr. Y. Yanagawa. Pitx3-GFP
is a knock-in mouse that was kindly provided by Dr. M. Li. All procedures
were performed in the light cycle using IACUC approved protocols for animal
handling at the Salk Institute and the University of Geneva.
Drug Treatment
Male and femalemice (P15-35) were injected intraperitoneally with 0.9%saline
(control), 2 mg/kg methamphetamine (METH), or 15 mg/kg cocaine using a
15-gauge insulin syringe and injection volume <200 ml to minimize stress.
Experimental procedures were performed 24 hr–7 days later. Methamphet-
amine and cocaine were purchased from Sigma (St. Louis, MO, USA).
Electrophysiology in Acute Slices
Twenty-four hours or 7 days following i.p. injections,micewere euthanized and
horizontal slices from midbrain (250 mm) were prepared in ice-cold artificial
cerebral spinal fluid (see Supplemental Experimental Procedures for details).
Neurons were visualized with IR camera Gloor Instrument PCO or Dage-MTI
IR-1000) on an Olympus scope (BX50 or BX51) and whole-cell patch-clamp
recordings (Axopatch 200B or Multiclamp 700A amplifier) were made from
neurons in the VTA, identified as the region medial to the medial terminal
nucleus of the accessory optical tract. GABA neurons were identified by the
absence of Ih current, a small capacitance (<20 pF) and a fast spontaneous
firing rate (5–10 Hz). In contrast DA neurons have an Ih current, large capaci-
tance (20–50 pF) and slow spontaneous firing (1–3 Hz). Pitx3-GFP mice
expressing GFP in DA neurons (Zhao et al., 2004) and GAD67-GFP mice
expressing GFP in GABA neurons (Tamamaki et al., 2003) were used to
confirm electrophysiological identification. The internal solution for measuring
baclofen-activated GABAB currents contained (in mM) potassium gluconate
140, NaCl 4, MgCl2 2, EGTA 1.1, HEPES 5, Na2ATP 2, sodium creatine phos-
phate 5 and Na3GTP 0.6 (pH 7.3) with KOH. For GABAB sIPSCs, the internal
solution contained (in mM) K-gluconate 140, KCl 5, MgCl2 2, EGTA 0.2, HEPES
10, Na2ATP 4, Creatine-phosphate 10, and Na3GTP 0.3. To measure GABAA
currents, the internal solution contained (in mM) K-gluconate 30, KCl 100,
MgCl2 4, creatine phosphate 10, Na2 ATP 3.4, Na3 GTP 0.1, EGTA 1.1, and
HEPES 5.
For the sIPSC, the evoked synaptic recordings were isolated in presence of
APV (100 mM), NBQX (10 mM), and sulpiride (200 nM) for GABAAR IPSC, and
picrotoxin (100 mM) for GABABR sIPSC. The stimulation electrode consisted
of a saline-filled monopolar glass pipet placed caudally to the cell being
recorded. GABAAR paired-pulse ratio (PPR) was assessed by applying two
pulses at 50 ms interval every 10 s, whereas the GABABR sIPSCs were evoked
by applying a train of 10 electrical pulses at 66Hz once every 20–40 s. For
IBaclofen, currents were recorded, filtered at 1 kHz and digitized at 5 kHz
(Axon pClamp 8). Cells were clamped at 50 or 60 mV (membrane voltages
were corrected for liquid junction potential; 15.7 mV). For some recordings,
a voltage ramp from +60mV to100mVwas delivered at 1 Hz. Cell membrane
resistance and approximate access resistance were measured with a 200 ms
10 mV hyperpolarizing step. All electrophysiological chemicals for electro-
physiology were purchased from Sigma; drugs were purchased from Tocris
Bioscience (Minneapolis, MN). We did not observe any differences with
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Depression of GABABR-GIRKs with Psychostimulantswild-type mice and Pitx3-GFP or GAD67-GFP; therefore, we have pooled the
data. Data are expressed as mean ± SEM and statistical significance (p < 0.05)
determined by one-way analysis of variance (ANOVA) with Holm-Sidak post
hoc test, Student’s t test, or Mann-Whitney test. All measurements made at
33C.
Optogenetic Experiment
AAV5-flox-ChR2-eYFPvirus (produced in theVectorCore Facility at theUniver-
sity of North Carolina) was injected into 3-week-old GAD65-Cre mice (kindly
provided by Dr. Gero Miesenbo¨ck). Anesthesia was induced and maintained
with isoflurane (Baxter AG, Vienna, Austria) at 5% and 1%, respectively. The
animal was placed in a stereotaxic frame (Angle One; Leica, Solms, Germany)
and craniotomies were performed bilaterally over the VTA using stereotaxic
coordinates (AP 3.4, ML ± 0.8, and DV 4.4). Injections of AAV-ChR2 flox
were carried out using graduated pipets (Drummond Scientific Company,
Broomall, PA, USA), broken back to a tip diameter of 10–15 mm, at a rate of
100 nl min-1 for a total volume of 500 nl. In all experiments the virus was al-
lowed 3 weeks to incubate before any other procedures were carried out.
Fast GABAA IPSCs in DA cells were isolated in presence of kynurenic acid
(2 mM) and evoked by applying two consecutive 4 ms blue-light (Thorlad–
472 nm LED) flashes at 50 ms interval to the slice every 10 s. Recordings
were made as described previously.
Antibodies
A rabbit polyclonal antibody anti-Glutamate Decarboxylase 65 & 67 (AB1511;
Millipore, Billerica, MA, USA), anti-GAPDH (Santa Cruz Biotechnology, Santa
Cruz, CA, USA), anti-phospho S783-GABAB2 (p-S783; Terunuma et al.,
2010), anti-phospho S892-GABAB2 (p-S892; Couve et al., 2001) were used.
A monoclonal antibody anti-GABAB1 (Clone N93A/49; NeuroMab, Davis, CA,
USA) and anti-GABAB2 (Clone N81/37; NeuroMab) were used. A guinea-pig
polyclonal antibody anti-GIRK2 (Aguado et al., 2008) was used.
Immunoelectron Microscopy
A similar procedure to that described earlier (Lujan et al., 1996; Koyrakh et al.,
2005) was used. See online Supplemental Experimental Procedures for details
on procedures and quantitation.
Western Blotting
Tissue punches from VTA, NAc, hippocampus, and mPFC obtained from
saline- and METH-injected mice were lysed in 20 mM Tris-HCl (pH 8.0),
150 mM NaCl, 5 mM EDTA, 1% Triton X-100, 10 mM NaF, 2 mM Na3VO4,
10 mM Na4P2O7, 10 mg/ml leupeptin, 1 mg/ml aprotinin, 10 mg/ml antipain,
and 250 mg/ml 4-(2-Aminoethl) benzenesulfonyl fluoride hydrochloride.
Soluble material was then subjected to immunoblotting with anti-GABAB2,
anti-phospho S783-GABAB2 (p-S783), anti-phospho S892-GABAB2 (p-S892),
anti-GAPDH, and detected by SuperSignal West Dura Chemiluminescent
Substrate (Thermo Scientific, Rockford, IL, USA). The luminescence images
were captured by a Luminescent Image Analyzer (LAS3000; Fujifilm, Tokyo,
Japan) and the intensity of bands were measured by Multi Gauge software
(version 3; Fujifilm).
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